{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: RESEARCH DESIGN AND METHODS : EndoMT was induced in a mouse pancreatic microvascular endothelial cell line ( MMEC ) in the presence of advanced glycation end products ( AGEs ) and in the endothelial lineage - traceble mouse line Tie2 - Cre ; Loxp - EGFP by administration of AGEs , with nonglycated mouse albumin serving as a control .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Endothelial-to-mesenchymal transition (EndoMT) |\n\nIn this paragraph, the disease entity mentioned is Endothelial-to-mesenchymal transition (EndoMT)."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Endothelial-to-mesenchymal transition (EndoMT) |\n\nIn the given paragraph, the only clearly mentioned disease entity is Endothelial-to-mesenchymal transition (EndoMT). Other entities such as \"mouse pancreatic microvascular endothelial cell line (MMEC)\", \"mouse line Tie2 - Cre ; Loxp - EGFP\", \"AGEs\", and \"nonglycated mouse albumin\" are not disease entities but rather research tools or conditions used in the study."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: RESEARCH DESIGN AND METHODS : EndoMT was induced in a mouse pancreatic microvascular endothelial cell line ( MMEC ) in the presence of advanced glycation end products ( AGEs ) and in the endothelial lineage - traceble mouse line Tie2 - Cre ; Loxp - EGFP by administration of AGEs , with nonglycated mouse albumin serving as a control .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| advanced glycation end products (AGEs) |\n| nonglycated mouse albumin |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| advanced glycation end products (AGEs) |\n| nonglycated mouse albumin |"}
  ]
}